Laurantis Pharma Oy
Turku, FI· latest recorded location
LAURANTIS PHARMA OY is named on 1 US grants and 3 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 1
- Published applications
- 3
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 7 Oct 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Technology areas
Share of 4 documents
Recent patents
- Therapeutic use of vegf-c and ccbe11 Jul 2021US 2021/0196795 A1
- Therapeutic use of vegf-c and ccbe17 Jul 2016US 2016/0193298 A1
- Autologous Lymph Node Transfer In Combination With VEGF-C Or VEGF-D Growth Factor Therapy to Treat Lymphedema And To Improve Reconstructive Surgery27 Mar 2014US 2014/0087002 A1
Most cited
By later US patents